\relax 
\providecommand\hyper@newdestlabel[2]{}
\providecommand\HyperFirstAtBeginDocument{\AtBeginDocument}
\HyperFirstAtBeginDocument{\ifx\hyper@anchor\@undefined
\global\let\oldcontentsline\contentsline
\gdef\contentsline#1#2#3#4{\oldcontentsline{#1}{#2}{#3}}
\global\let\oldnewlabel\newlabel
\gdef\newlabel#1#2{\newlabelxx{#1}#2}
\gdef\newlabelxx#1#2#3#4#5#6{\oldnewlabel{#1}{{#2}{#3}}}
\AtEndDocument{\ifx\hyper@anchor\@undefined
\let\contentsline\oldcontentsline
\let\newlabel\oldnewlabel
\fi}
\fi}
\global\let\hyper@last\relax 
\gdef\HyperFirstAtBeginDocument#1{#1}
\providecommand*\HyPL@Entry[1]{}
\abx@aux@refcontext{nty/global//global/global}
\HyPL@Entry{0<</S/D>>}
\@writefile{toc}{\boolfalse {citerequest}\boolfalse {citetracker}\boolfalse {pagetracker}\boolfalse {backtracker}\relax }
\@writefile{lof}{\boolfalse {citerequest}\boolfalse {citetracker}\boolfalse {pagetracker}\boolfalse {backtracker}\relax }
\@writefile{lot}{\boolfalse {citerequest}\boolfalse {citetracker}\boolfalse {pagetracker}\boolfalse {backtracker}\relax }
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {section}{Data description and filtering}{1}{section*.1}}
\newlabel{data-description-and-filtering}{{}{1}{Data description and filtering}{section*.1}{}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S1}{\ignorespaces Barplot of the time difference between GFR and serum creatinine measurements for each patient. A negative difference indicates that the serum creatinine was measured after the GFR. Some centres only reported time ranges for the creatinine, i.e.\nobreakspace  {}that it was measured within 30 days of GFR, and not specific dates. Data from these centres were not included for this barplot.}}{2}{figure.1}}
\newlabel{fig:date_diff_barplot}{{S1}{2}{Barplot of the time difference between GFR and serum creatinine measurements for each patient. A negative difference indicates that the serum creatinine was measured after the GFR. Some centres only reported time ranges for the creatinine, i.e.~that it was measured within 30 days of GFR, and not specific dates. Data from these centres were not included for this barplot}{figure.1}{}}
\@writefile{lot}{\defcounter {refsection}{0}\relax }\@writefile{lot}{\contentsline {table}{\numberline {S1}{\ignorespaces Creatinine methods used at each centre}}{2}{table.1}}
\newlabel{tab:creat_info}{{S1}{2}{Creatinine methods used at each centre}{table.1}{}}
\gdef \LT@i {\LT@entry 
    {5}{97.67049pt}\LT@entry 
    {5}{34.77525pt}\LT@entry 
    {5}{29.7136pt}\LT@entry 
    {1}{45.8718pt}\LT@entry 
    {5}{34.77525pt}\LT@entry 
    {1}{41.85002pt}\LT@entry 
    {6}{34.77525pt}\LT@entry 
    {1}{51.44006pt}}
\newlabel{tab:print_data_characteristic_tables}{{S2}{3}{Data description and filtering}{table.2}{}}
\newlabel{tab:summary_centre}{{S2}{3}{Data description and filtering}{table.2}{}}
\@writefile{lot}{\defcounter {refsection}{0}\relax }\@writefile{lot}{\contentsline {table}{\numberline {S2}{Summary characteristics from each centre}}{3}{table.2}}
\@writefile{lot}{\defcounter {refsection}{0}\relax }\@writefile{lot}{\contentsline {table}{\numberline {S3}{\ignorespaces Number of patients with given diagnoses in each centre}}{4}{table.3}}
\newlabel{tab:print_data_diagnosis}{{S3}{4}{Number of patients with given diagnoses in each centre}{table.3}{}}
\newlabel{tab:summary_diagnosis}{{S3}{4}{Number of patients with given diagnoses in each centre}{table.3}{}}
\newlabel{tab:summary_centre}{{S2}{4}{Data description and filtering}{table.2}{}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S2}{\ignorespaces Boxplot of the continuous variables split by centre. Creatinine has been log transformed.}}{5}{figure.2}}
\newlabel{fig:centre_boxplot}{{S2}{5}{Boxplot of the continuous variables split by centre. Creatinine has been log transformed}{figure.2}{}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S3}{\ignorespaces Boxplots of the serum creatinine of patients from different centres. Boxplots are shown for all patients combined and for patients with Germ Cell Tumours (GCT), Bladder or Transitional cell cancer (TCC), Thoracic cancer, Gastro-oesophageal cancer and Head and Neck cancer. The notches in the boxplots are \(1.58 \text  {IQR} / \sqrt  {n}\) (where \(n\) is the number of patients used for the given boxplot and IQR is the inter quartile range); they provide both an approximate 95\% confidence interval for the median and an indication of the number of patients used for the given boxplot.}}{6}{figure.3}}
\newlabel{fig:boxplot_creat}{{S3}{6}{Boxplots of the serum creatinine of patients from different centres. Boxplots are shown for all patients combined and for patients with Germ Cell Tumours (GCT), Bladder or Transitional cell cancer (TCC), Thoracic cancer, Gastro-oesophageal cancer and Head and Neck cancer. The notches in the boxplots are \(1.58 \text {IQR} / \sqrt {n}\) (where \(n\) is the number of patients used for the given boxplot and IQR is the inter quartile range); they provide both an approximate 95\% confidence interval for the median and an indication of the number of patients used for the given boxplot}{figure.3}{}}
\@writefile{lot}{\defcounter {refsection}{0}\relax }\@writefile{lot}{\contentsline {table}{\numberline {S4}{\ignorespaces t-test p-values for comparing the mean age, log(creatinine), GFR and BSA between 22 patients who were ethnically black and 22 random patients who were ethnically white and matched by mean age (mean age within 1 year) and the same gender distribution (12 females and 10 males).}}{6}{table.4}}
\newlabel{tab:ethnicity_matched_sampling}{{S4}{6}{t-test p-values for comparing the mean age, log(creatinine), GFR and BSA between 22 patients who were ethnically black and 22 random patients who were ethnically white and matched by mean age (mean age within 1 year) and the same gender distribution (12 females and 10 males)}{table.4}{}}
\newlabel{tab:race_resample}{{S4}{6}{t-test p-values for comparing the mean age, log(creatinine), GFR and BSA between 22 patients who were ethnically black and 22 random patients who were ethnically white and matched by mean age (mean age within 1 year) and the same gender distribution (12 females and 10 males)}{table.4}{}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S4}{\ignorespaces Boxplot of the continuous variables split by diagnosis. Subgroups with more than 50 patients are displayed. Subgroups with fewer than 50 patients have been combined with patients with an unknown diagnosis into the group Other. Boxplots are arranged by decreasing patient numbers from left to right. Serum creatinine has been log transformed.}}{7}{figure.4}}
\newlabel{fig:boxplot_diagnosis}{{S4}{7}{Boxplot of the continuous variables split by diagnosis. Subgroups with more than 50 patients are displayed. Subgroups with fewer than 50 patients have been combined with patients with an unknown diagnosis into the group Other. Boxplots are arranged by decreasing patient numbers from left to right. Serum creatinine has been log transformed}{figure.4}{}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S5}{\ignorespaces Boxplots of age, BSA, GFR and log(creatinine) and Age where patients are split by ethnicity. The `*' or `ns' at the top of the boxplot represents the p-value from a t-test between the largest subgroup of white patients and each other ethnic subgroups, where `ns' represents a p-value greater than 0.05 and `*', `**' and `***' represent p-values less than 0.05, 0.01 and 0.001 respectively.}}{8}{figure.5}}
\newlabel{fig:boxplot_race}{{S5}{8}{Boxplots of age, BSA, GFR and log(creatinine) and Age where patients are split by ethnicity. The `*' or `ns' at the top of the boxplot represents the p-value from a t-test between the largest subgroup of white patients and each other ethnic subgroups, where `ns' represents a p-value greater than 0.05 and `*', `**' and `***' represent p-values less than 0.05, 0.01 and 0.001 respectively}{figure.5}{}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {section}{Comparison of models}{9}{section*.2}}
\newlabel{comparison-of-models}{{}{9}{Comparison of models}{section*.2}{}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S6}{\ignorespaces Comparison of GFR estimated by CamGFR and CKD-EPI, the two best performing model. A) Bland-Altman plot of GFR estimated using the CamGFR and CKD-EPI models. B) Residual (GFR - eGFR) vs fitted value (eGFR) for both the CamGFR and CKD-EPI models.}}{10}{figure.6}}
\newlabel{fig:CKD_CamGFR_plot}{{S6}{10}{Comparison of GFR estimated by CamGFR and CKD-EPI, the two best performing model. A) Bland-Altman plot of GFR estimated using the CamGFR and CKD-EPI models. B) Residual (GFR - eGFR) vs fitted value (eGFR) for both the CamGFR and CKD-EPI models}{figure.6}{}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S7}{\ignorespaces Performance of GFR models for patients from different diagnostic subgroups. The results for the CamGFR model and four other commonly used models (CKD-EPI, Wright, MDRD-186 and Cockcroft-Gault) are displayed. Results for those diagnostic subgroups that had more than 50 patients are shown. First row: the residual (measured GFR - estimated GFR) median, which is a measure of a model's bias, is displayed. Second row: the residual interquartile range (IQR), which is a measure of a model's precision, is displayed. Third row: the root-mean-squared error (RMSE), which is a measure of a model's accuracy, is displayed. Accuracy is a combination metric of bias and precision. Fourth row: The proportion of patients who have an absolute percentage error more than 20\% (1-P20), which reflects clinical robustness by illustrating the proportion of patients with a clinically relevant error, is displayed. The best result would be closest to zero for the residual median, and the smallest value for IQR, RMSE, and 1-P20. All error bars are 95\% confidence intervals calculated using bootstrap resampling with 2,000 repetitions and a normal distribution approximation.}}{11}{figure.7}}
\newlabel{fig:performace_diagnosis}{{S7}{11}{Performance of GFR models for patients from different diagnostic subgroups. The results for the CamGFR model and four other commonly used models (CKD-EPI, Wright, MDRD-186 and Cockcroft-Gault) are displayed. Results for those diagnostic subgroups that had more than 50 patients are shown. First row: the residual (measured GFR - estimated GFR) median, which is a measure of a model's bias, is displayed. Second row: the residual interquartile range (IQR), which is a measure of a model's precision, is displayed. Third row: the root-mean-squared error (RMSE), which is a measure of a model's accuracy, is displayed. Accuracy is a combination metric of bias and precision. Fourth row: The proportion of patients who have an absolute percentage error more than 20\% (1-P20), which reflects clinical robustness by illustrating the proportion of patients with a clinically relevant error, is displayed. The best result would be closest to zero for the residual median, and the smallest value for IQR, RMSE, and 1-P20. All error bars are 95\% confidence intervals calculated using bootstrap resampling with 2,000 repetitions and a normal distribution approximation}{figure.7}{}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S8}{\ignorespaces Comparison of model performance in different age groups. The results for five published models are shown. Patients were split into 10 equally sized groups by their age. (\emph  {a},\emph  {b}{]} denotes the interval \emph  {a} to \emph  {b} which is exclusive of the lower and inclusive of the higher age.}}{12}{figure.8}}
\newlabel{fig:performace_age}{{S8}{12}{Comparison of model performance in different age groups. The results for five published models are shown. Patients were split into 10 equally sized groups by their age. (\emph {a},\emph {b}{]} denotes the interval \emph {a} to \emph {b} which is exclusive of the lower and inclusive of the higher age}{figure.8}{}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S9}{\ignorespaces Comparison of model performance in different BSA groups. The results for five published models are shown. Patients were split into 10 equally sized groups by their BSA. (\emph  {a},\emph  {b}{]} denotes the interval \emph  {a} to \emph  {b} which is exclusive of the lower and inclusive of the higher BSA.}}{13}{figure.9}}
\newlabel{fig:performace_BSA}{{S9}{13}{Comparison of model performance in different BSA groups. The results for five published models are shown. Patients were split into 10 equally sized groups by their BSA. (\emph {a},\emph {b}{]} denotes the interval \emph {a} to \emph {b} which is exclusive of the lower and inclusive of the higher BSA}{figure.9}{}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S10}{\ignorespaces Comparison of model performance in different BSA groups. The results for five published models are shown. Patients were split into 10 equally sized groups by their BSA. (\emph  {a},\emph  {b}{]} denotes the interval \emph  {a} to \emph  {b} which is exclusive of the lower and inclusive of the higher BSA.}}{14}{figure.10}}
\newlabel{fig:performace_Creat}{{S10}{14}{Comparison of model performance in different BSA groups. The results for five published models are shown. Patients were split into 10 equally sized groups by their BSA. (\emph {a},\emph {b}{]} denotes the interval \emph {a} to \emph {b} which is exclusive of the lower and inclusive of the higher BSA}{figure.10}{}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S11}{\ignorespaces Comparison of model performance patients split by the difference in time between the GFR and creatinine measurement dates. The results for five published models are shown. A negative date difference corresponds to creatinine measured after GFR.}}{15}{figure.11}}
\newlabel{fig:performace_date_diff}{{S11}{15}{Comparison of model performance patients split by the difference in time between the GFR and creatinine measurement dates. The results for five published models are shown. A negative date difference corresponds to creatinine measured after GFR}{figure.11}{}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {section}{Published models}{17}{section*.3}}
\newlabel{published-models}{{}{17}{Published models}{section*.3}{}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsection}{CamGFR\textsuperscript  {1}}{17}{section*.4}}
\newlabel{camgfr-janowitz2017a}{{}{17}{\texorpdfstring {CamGFR\textsuperscript {1}}{CamGFR1}}{section*.4}{}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsection}{CKD-EPI\textsuperscript  {2}}{17}{section*.5}}
\newlabel{ckd-epi-levey2009}{{}{17}{\texorpdfstring {CKD-EPI\textsuperscript {2}}{CKD-EPI2}}{section*.5}{}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsection}{Cockcroft Gault\textsuperscript  {5}}{17}{section*.6}}
\newlabel{cockcroft-gault-cockcroft1976}{{}{17}{\texorpdfstring {Cockcroft Gault\textsuperscript {5}}{Cockcroft Gault5}}{section*.6}{}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsection}{MDRD-186\textsuperscript  {11}}{17}{section*.7}}
\newlabel{mdrd-186-levey2006}{{}{17}{\texorpdfstring {MDRD-186\textsuperscript {11}}{MDRD-18611}}{section*.7}{}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsection}{Jelliffe\textsuperscript  {6}}{17}{section*.8}}
\newlabel{jelliffe-jelliffe1973}{{}{17}{\texorpdfstring {Jelliffe\textsuperscript {6}}{Jelliffe6}}{section*.8}{}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsection}{Wright\textsuperscript  {4}}{17}{section*.9}}
\newlabel{wright-wright2001}{{}{17}{\texorpdfstring {Wright\textsuperscript {4}}{Wright4}}{section*.9}{}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsection}{Mayo Quadratic\textsuperscript  {7}}{18}{section*.10}}
\newlabel{mayo-quadratic-rule2004}{{}{18}{\texorpdfstring {Mayo Quadratic\textsuperscript {7}}{Mayo Quadratic7}}{section*.10}{}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsection}{Martin\textsuperscript  {8}}{18}{section*.11}}
\newlabel{martin-martin1998}{{}{18}{\texorpdfstring {Martin\textsuperscript {8}}{Martin8}}{section*.11}{}}
\newlabel{references}{{}{18}{References}{section*.12}{}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {section}{References}{18}{section*.12}}
